View in EDS

Epcoritamab as bridging therapy to successful second allogeneic HSCT in relapsed DLBCL after UCBT and CAR T cell therapy.

Saved in:
Bibliographic Details
Title: Epcoritamab as bridging therapy to successful second allogeneic HSCT in relapsed DLBCL after UCBT and CAR T cell therapy.
Authors: Chikagawa Y; Department of Internal Medicine, Komatsu Municipal Hospital, 60, Mukaimotoori-Machi, Komatsu, Ishikawa, 923-8560, Japan. ychikagawa.n1@gmail.com.; Department of Hematology, Kanazawa Medical Center, 1-1, Shimoishibiki-Machi, Kanazawa, Ishikawa, 920-8650, Japan. ychikagawa.n1@gmail.com., Higashi D; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Sakai S; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Yoshino H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Nukii Y; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Mura H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Nakagawa S; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Yamada S; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Yoroidaka T; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Imi T; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Zaimoku Y; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Maruyama H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Hosokawa K; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Aoki G; Department of Internal Medicine, Komatsu Municipal Hospital, 60, Mukaimotoori-Machi, Komatsu, Ishikawa, 923-8560, Japan., Yoshida A; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Takamatsu H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Yamazaki H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Miyamoto T; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.
Source: International journal of hematology [Int J Hematol] 2026 Jan; Vol. 123 (1), pp. 141-145. Date of Electronic Publication: 2025 Oct 27.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41143946
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Epcoritamab as bridging therapy to successful second allogeneic HSCT in relapsed DLBCL after UCBT and CAR T cell therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chikagawa+Y%22">Chikagawa Y</searchLink>; Department of Internal Medicine, Komatsu Municipal Hospital, 60, Mukaimotoori-Machi, Komatsu, Ishikawa, 923-8560, Japan. ychikagawa.n1@gmail.com.; Department of Hematology, Kanazawa Medical Center, 1-1, Shimoishibiki-Machi, Kanazawa, Ishikawa, 920-8650, Japan. ychikagawa.n1@gmail.com.<br /><searchLink fieldCode="AU" term="%22Higashi+D%22">Higashi D</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Sakai+S%22">Sakai S</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshino+H%22">Yoshino H</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Nukii+Y%22">Nukii Y</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Mura+H%22">Mura H</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Nakagawa+S%22">Nakagawa S</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Yamada+S%22">Yamada S</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Yoroidaka+T%22">Yoroidaka T</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Imi+T%22">Imi T</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Zaimoku+Y%22">Zaimoku Y</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Maruyama+H%22">Maruyama H</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Hosokawa+K%22">Hosokawa K</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Aoki+G%22">Aoki G</searchLink>; Department of Internal Medicine, Komatsu Municipal Hospital, 60, Mukaimotoori-Machi, Komatsu, Ishikawa, 923-8560, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+A%22">Yoshida A</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Takamatsu+H%22">Takamatsu H</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Yamazaki+H%22">Yamazaki H</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.<br /><searchLink fieldCode="AU" term="%22Miyamoto+T%22">Miyamoto T</searchLink>; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229111627%22">International journal of hematology</searchLink> [Int J Hematol] 2026 Jan; Vol. 123 (1), pp. 141-145. <i>Date of Electronic Publication: </i>2025 Oct 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Japan%22">Springer Japan </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9111627 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-3774 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209255710%22">09255710 </searchLink><i>NLM ISO Abbreviation: </i>Int J Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41143946
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12185-025-04091-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 141
    Titles:
      – TitleFull: Epcoritamab as bridging therapy to successful second allogeneic HSCT in relapsed DLBCL after UCBT and CAR T cell therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chikagawa Y
      – PersonEntity:
          Name:
            NameFull: Higashi D
      – PersonEntity:
          Name:
            NameFull: Sakai S
      – PersonEntity:
          Name:
            NameFull: Yoshino H
      – PersonEntity:
          Name:
            NameFull: Nukii Y
      – PersonEntity:
          Name:
            NameFull: Mura H
      – PersonEntity:
          Name:
            NameFull: Nakagawa S
      – PersonEntity:
          Name:
            NameFull: Yamada S
      – PersonEntity:
          Name:
            NameFull: Yoroidaka T
      – PersonEntity:
          Name:
            NameFull: Imi T
      – PersonEntity:
          Name:
            NameFull: Zaimoku Y
      – PersonEntity:
          Name:
            NameFull: Maruyama H
      – PersonEntity:
          Name:
            NameFull: Hosokawa K
      – PersonEntity:
          Name:
            NameFull: Aoki G
      – PersonEntity:
          Name:
            NameFull: Yoshida A
      – PersonEntity:
          Name:
            NameFull: Takamatsu H
      – PersonEntity:
          Name:
            NameFull: Yamazaki H
      – PersonEntity:
          Name:
            NameFull: Miyamoto T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1865-3774
          Numbering:
            – Type: volume
              Value: 123
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: International journal of hematology
              Type: main
ResultId 1